Insider Cluster (2 insiders) ·Filed Aug 21, 2026

ZLAB

Zai Lab Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $220K total
Actionable Insight • Neutral

Ignore this insider cluster. The $220K in sales is noise for a $2.9B company. Monitor ZLAB's next pipeline catalyst (e.g., regulatory updates on VYVGART or ZEJULA) for real trading signals, not insider selling patterns.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
ZLAB ▲ +1.61% at T+20d
NEUTRAL call ✓ call won +1.61% · α vs SPY +2.14% · entry $26.01 → $26.43
Next anchor: T+60d in 6w
Latest observation: T+27 -10.05% FF3 residual α
Entry anchored
Aug 20, 04:00 PM ET
via 1-min bar
T+1d
-1.42%
call -1.42% · α -1.13%
$25.64
settled 6w ago
T+5d
+0.27%
call +0.27% · α -0.20%
$26.08
settled 5w ago
T+20d
+1.61%
call +1.61% · α +2.14%
$26.43
settled 14d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Two Zai Lab insiders — Director William Lis and CFO Yajing Chen — sold a combined $220K in open-market sales over an 8-day window. The total value is 0.008% of the $2.9B market cap, well below the 0.1% materiality threshold, making this a routine, non-informative cluster. Per academic literature, cluster sales are not predictive of returns, and the dollar amounts here are trivial relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$220.0K
Insiders
2

Key Facts

  • Director William Lis sold 8,500 shares at ~$25.00 for $213K on 2026-08-12.
  • CFO Yajing Chen sold 260 shares at ~$27.00 for $7K on 2026-08-19.
  • Total cluster value is $220K, representing 0.008% of ZLAB's $2.9B market cap.
  • Both transactions were open-market sales (code S). No insider purchases occurred in the cluster.
  • The cluster is too small to be economically meaningful — no insider is signaling a bearish view.

Financial Impact

$220K total insider sales, 0.008% of market cap — trivial

Risk Factors

  • No material risk from this filing — insider sales are routine and immaterial.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ZLAB-1787379228632
20 reports for ZLAB
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +13.13%May 7, 2026
Filters
Rows
Reports for ZLAB — sortable, filterable
TypeNow
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.01 $26.08▲ +0.27%▼ −0.20%$24.33 (−6.46%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.03 $26.02▼ −0.04%▲ +1.93%$24.33 (−6.53%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.03 $26.02▼ −0.04%▲ +1.93%$24.33 (−6.53%)
Aug 12, 2026
7w ago
144
NEUTRAL ★ 2/10
$25.49 $26.72▲ +4.83%▲ +5.27%$24.33 (−4.55%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$19.15 $19.35▲ +1.04%▲ +0.78%$24.33 (+27.05%)
Jun 29, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$19.00 $19.08▲ +0.42%▼ −0.18%$24.33 (+28.05%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 5/10
$17.64 $17.88▼ −1.36%▼ −0.93%$24.33 (−37.93%)
May 21, 2026
19w ago
8-K
NEUTRAL ★ 4/10
$18.61 $17.09▼ −8.17%▼ −9.83%$24.33 (+30.74%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.81 $18.69▼ −0.64%▼ −1.88%$24.33 (+29.35%)
May 19, 2026
19w ago
Insider Cluster
BEARISH ★ 6/10
$18.81 $18.69▲ +0.64%▲ +1.88%$24.33 (−29.35%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (39h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 22, 2026